The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin

Anesthesia and Analgesia

Volumn 110, Issue 2, 2010, Pages 365-369

  Jerath, Angela ^a   Srinivas, Coimbatore ^a   Vegas, Annette ^a   Brister, Stephanie ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMIODARONE; ATORVASTATIN; CEFAZOLIN; DOPAMINE; FENTANYL; FUROSEMIDE; HEPARIN; METOPROLOL; MIDAZOLAM; MILRINONE; NORADRENALIN; PANCURONIUM; PROPOFOL; PROSTACYCLIN; PROTAMINE; TRANEXAMIC ACID; WARFARIN; ANTIHYPERTENSIVE AGENT; HEPARIN ANTAGONIST;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY BYPASS SURGERY; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG DOSE REDUCTION; ELECTIVE SURGERY; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG ARTERY PRESSURE; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; CORONARY ARTERY BYPASS GRAFT; INHALATIONAL DRUG ADMINISTRATION; PERIOPERATIVE PERIOD;

ACUTE DISEASE; ADMINISTRATION, INHALATION; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CORONARY ARTERY BYPASS; EPOPROSTENOL; HEPARIN ANTAGONISTS; HUMANS; HYPERTENSION, PULMONARY; MALE; PERIOPERATIVE CARE; PROTAMINES;

EID: 76249124149     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181c6bbf0     Document Type: Article

References (27)

1. Horrow JC. Protamine: a review of its toxicity. Anesth Analg 1985;64:348-361
2. Park KW. Protamine and protamine reactions. Intern Anesth Clinics 2004;42:135-145
3. Lowenstein E, Johnston WE, Lappas DG, D'Ambra MN, Schneider RC, Daggett WM, Akins CW, Philbin DM. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology 1983;59:470-473
4. Morel DR, Zapol WM, Thomas SJ, Kitain EM, Robinson DR, Moss J, Chenoweth DE, Lowenstein E. C5a and thromboxane generation associated with pulmonary vaso- and bronchoconstriction during protamine reversal of heparin. Anesthesiology 1987;66:597-604
5. Doolan L, McKenzie I, Krafchek J, Parsons B, Buxton B. Protamine sulphate hypersensitivity. Anaesth Intensive Care 1981;9: 147-149
6. Mertes PM, Laxenaire MC. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 2002;19:240-262
7. Levy JH. Anaphylaxis and adverse drug reactions. In: Schwartz AJ, ed. Refresher courses in anesthesiology. Vol 33. Philadelphia, PA: Lippincott Williams & Wilkins, 2004:155-163
8. Levy JH, Zaidan JR, Faraj B. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes. Anesth Analg 1986;65:739-742
9. Kimmel SE, Sekeres MA, Berlin JA, Ellison N, DiSesa VJ, Strom BL. Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass. J Am Coll Cardiol 1998;32:1916-1922
10. Hobbhahn J, Conzen PF, Zenker B, Goetz AE, Peter K, Brendel W. Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine. Anesth Analg 1988; 67:253-260
11. Conzen PF, Habazettl H, Gutmann R, Hobbhahn J, Goetz AE, Peter K, Brendel W. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs. Anesth Analg 1989;68:25-31
12. Comunale ME, Maslow A, Robertson LK, Haering M, Mashikian JS, Lowenstein E. Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction. J Cardiothorac Vasc Anesth 2003;17:309-313
13. Wetzel R. Aersolized prostacyclin. In search of the ideal pulmonary vasodilator. Anesthesiology 1995;82:1315-1317
14. Katircioglu SF, Ulus T, Yamak B, Saritas Z, Yildiz U. Experimental inhibition of protamine cardiotoxicity by prostacyclin. Angiology 1999;50:929-935
15. Ocal A, Kiris I, Erdinc M, Peker O, Yavuz T, Ibrisim E. Efficiency of prostacyclin in the treatment of protamine-mediated right ventricular failure and acute pulmonary hypertension. Tohoku J Exp Med 2005;207:51-58
16. Van Heerden PV, Barden A, Michalopoulos N, Bulsara MK, Roberts BL. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest 2000;117:819-827
17. MacKnight B, Martinez EA, Simon BA. Anesthetic management of patients with pulmonary hypertension. Semin Cardiothorac Vasc Anesth 2008;12:91-96
18. Lowson SM. Alternatives to nitric oxide. Brit Med Bull 2004;70:119-131
19. De Wet CJ, Affleck DG, Jacobsohn E, Avidan MS, Tymkew H, Hill LL, Zanaboni PB, Moazami N, Smith JR. Inhaled prostacyclin is safe, effective and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 2004;127:1058-1067
20. Haraldsson A, Kiler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 1998;114:780-786
21. Haraldsson A, Kieler-Jensen N, Ricksten SE. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 1996;10:864-868
22. Zwissler B, Rank N, Jaenicke U, Schurle B, Welte M, Reichart B, Netz H, Messmer K, Peter K. Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology 1995;82:1512-1516
23. Siobel MS, Kallet RH, Pittet JF, Warnecke EL, Kramer RW, Venkayya RV, Tang JF. Description and evaluation of a delivery system for aerosolised prostacyclin. Respir Care 2003; 48:742-753
24. Ralley FE. The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration. Anesth Analg 1999;88:505-507
25. Fratacci MD, Frostell CG, Chen TY, Wain JC Jr, Robinson DR, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991;75:990-999
26. Haj RM, Cinco E, Mazer CD. Treatment of pulmonary hypertension with selective pulmonary vasodilators. Curr Opin Anaesthesiol 2006;19:88-95
27. Siobal MS. Pulmonary vasodilators. Respir Care 2007;52:885-899